Moderna and Merck said a personalized mRNA cancer vaccine reduced the risk of melanoma recurrence and spread in a late-stage trial, sending Moderna shares soari

Crime News • 2026-08-20 00:45 UTC • By Billy Odell Tucker-Robinson

Moderna and Merck said a personalized mRNA cancer vaccine reduced the risk of melanoma recurrence and spread in a late-stage trial, sending Moderna shares soaring as much as 160% [▻](https://video.twimg.com/amplify_video/2090206536530300928/vid/avc1/1920x1080/OWNBgTQgJLLP…

Share this article

𝕏 X / Twitter Facebook LinkedIn WhatsApp

📚 More from Billy’s World

📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly